Premarket Biotech Digest: Eli Lilly's Necitumumab, A Focus On Amgen

Stock Information for Capstone Holding Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Capstone Holding Corp.

Capstone's 2026 Outlook Reaffirms $100M Run-Rate Target and Outlines Path to 10% EBITDA Margins
Capstone Strengthens North American Presence and Achieves Key Milestones in Canadian Stone Industries Integration
Capstone Closes Canadian Stone Industries Acquisition, Adding $15M Revenue and Expanding North American Footprint
Industry Research Signals Strong Demand Cycle Ahead as Capstone Enters 2026 with Expanded Scale and Margin Strength
Capstone Releases Q3 Investor Presentation and Transcript Highlighting Strong Growth and Acquisition Momentum
Capstone Reports Record Q3 Results With 46% EBITDA Growth and New Acquisition Momentum
Capstone Expands Stone Distribution Platform Amid Strong Market Tailwinds
Capstone Reaffirms $100 Million 2026 Run-Rate Target with Acquisition Closing by December 15th

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.